Beam Therapeutics Inc.

BEAM - Company ID 0001745999

Market cap$3.69 B

Rank#1671

Filings488

Beam Therapeutics Inc. has filed 488 public company documents between 2018 and 2026. The most frequent type is insider trade (194 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.

Continue researchBEAM overview$3.69 BMarket cap, financials, charts, and latest company context.

Continue researchMarket cap historyRank #1671See the market value trend behind the filing history.

Continue researchRevenue trendAnnual historyMove from documents into filing-backed operating results.

Continue researchCompare with AMGNPeer viewPut BEAM beside AMGN across market cap, revenue, income, and filings.

Browse latest filings across all companies →Follow BEAM via RSS

Similar companies to research next

AMGNAmgen Inc.

GILDGilead Sciences, Inc.AARGXargenx SE RRVMDRevolution Medicines, Inc.

MRNAModerna, Inc.

BIIBBiogen Inc.

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.

Type	Filing	Filed	Period covered	Open
DEF 14A	Proxy statement	2mo ago2026-04-17	2026-06-03	View filing
DEF 14A	Proxy statement	1y ago2025-04-18	2025-06-04	View filing
DEF 14A	Proxy statement	2y ago2024-04-19	2024-06-05	View filing
DEF 14A	Proxy statement	3y ago2023-04-21	-	View filing
DEF 14A	Proxy statement	4y ago2022-04-22	2022-06-08	View filing
DEF 14A	Proxy statement	5y ago2021-04-23	2021-06-09	View filing

Beam Therapeutics Inc.

Similar companies to research next

Year